Filing Flows › Roivant Sciences (ROIV) › Q1 FY27 › vs Q1 FY26
Roivant Sciences (ROIV) Q1 FY27 vs Q1 FY26 (year over year)
Roivant Sciences's revenue fell $728K (-34%) from $2.2M in Q1 FY26 to $1.4M in Q1 FY27.
Roivant Sciences, Q1 FY27: revenue $1.4M (-34% year over year), net loss $291M, operating cash flow −$271M. The chart draws each line against Q1 FY26, the increases inside each band.
Every line
| Line | Q1 FY27 | Q1 FY26 | Change | % |
|---|---|---|---|---|
| Revenue | $1.4M | $2.2M | −$728K | -34% |
| Other income, net | $71.4M | $15.7M | $55.8M | +356% |
| Income tax benefit | $4.0M | −$4.6M | $8.6M | — |
| Net loss | $291M | $274M | $16.7M | +6% |
| Costs & expenses | $367M | $292M | $75.7M | +26% |
| Operating costs | $367M | $287M | $80.3M | +28% |
| Research & development | $202M | $153M | $49.1M | +32% |
| General & admin | $166M | $134M | $31.5M | +24% |
| Operating cash sources | $354M | $288M | $66.8M | +23% |
| Depreciation & amortization | $600K | $1.1M | −$498K | -45% |
| Share-based compensation | $83.3M | $82.2M | $1.2M | +1% |
| Cash used in operations | $271M | $204M | $66.1M | +32% |
| Net loss absorbed | $291M | $274M | $16.7M | +6% |
| Working capital & other | $63.8M | $13.7M | $50.1M | +364% |
Questions
How much did Roivant Sciences's revenue grow year over year in Q1 FY27?
Roivant Sciences's revenue fell $728K (-34%) from $2.2M in Q1 FY26 to $1.4M in Q1 FY27.